{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:58:17Z","timestamp":1770843497643,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Endemic Burkitt's lymphoma (BL) is an extranodal tumor appearing predominantly in the jaw in younger children while abdominal tumors predominate with increasing age. Previous studies have identified elevated levels of antibodies to <jats:italic>Plasmodium falciparum<\/jats:italic> schizont extracts and Epstein-Barr virus (EBV) viral capsid antigens (VCA) in endemic BL relative to malaria exposed controls. However, these studies have neither determined if there were any differences based on the site of clinical presentation of the tumor nor examined a broader panel of EBV and <jats:italic>P. falciparum<\/jats:italic> antigens.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We used a suspension bead Luminex assay to measure the IgG levels against EBV antigens, VCA, EAd, EBNA-1 and Zta as well as <jats:italic>P. falciparum<\/jats:italic> MSP-1, LSA-1, and AMA-1 antigens in children with BL (n = 32) and in population-based age-and sex-matched controls (n = 25) from a malaria endemic region in Western Kenya with high incidence of BL. EBV viral load in plasma was determined by quantitative PCR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Relative to healthy controls, BL patients had significantly increased anti-Zta (<jats:italic>p<\/jats:italic> = 0.0017) and VCA IgG levels (<jats:italic>p<\/jats:italic> &lt; 0.0001) and plasma EBV viral loads (<jats:italic>p<\/jats:italic> &lt; 0.0001). In contrast, comparable IgG levels to all <jats:italic>P. falciparum<\/jats:italic> antigens tested were observed in BL patients compared to controls. Interestingly, when we grouped BL patients into those presenting with abdominal tumors or with jaw tumors, we observed significantly higher levels of anti-Zta IgG levels (<jats:italic>p<\/jats:italic> &lt; 0.0065) and plasma EBV viral loads (<jats:italic>p<\/jats:italic> &lt; 0.033) in patients with abdominal tumors compared to patients with jaw tumors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Elevated antibodies to Zta and elevated plasma EBV viral load could be relevant biomarkers for BL and could also be used to confirm BL presenting in the abdominal region.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1750-9378-5-13","type":"journal-article","created":{"date-parts":[[2010,7,29]],"date-time":"2010-07-29T09:41:04Z","timestamp":1280396464000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Elevated anti-Zta IgG levels and EBV viral load are associated with site of tumor presentation in endemic Burkitt's lymphoma patients: a case control study"],"prefix":"10.1186","volume":"5","author":[{"given":"Amolo S","family":"Asito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwan","family":"Piriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Sumba","family":"Odada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaap M","family":"Middeldorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheetij","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E","family":"Lanar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter GZO","family":"Jura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Collins","family":"Ouma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana A","family":"Otieno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann M","family":"Moormann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary","family":"Rochford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,28]]},"reference":[{"key":"163_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3109\/07853899809005852","volume":"30","author":"BE Griffin","year":"1998","unstructured":"Griffin BE, Xue SA: Epstein-Barr virus infections and their association with human malignancies: some key questions. Ann Med. 1998, 30: 249-259. 10.3109\/07853899809005852.","journal-title":"Ann Med"},{"key":"163_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0140-6736(77)91137-0","volume":"1","author":"G de-The","year":"1977","unstructured":"de-The G: Is Burkitt's lymphoma related to perinatal infection by Epstein-Barr virus?. Lancet. 1977, 1: 335-338. 10.1016\/S0140-6736(77)91137-0.","journal-title":"Lancet"},{"key":"163_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nrmicro1089","volume":"3","author":"R Rochford","year":"2005","unstructured":"Rochford R, Cannon MJ, Moormann AM: Endemic Burkitt's lymphoma: a polymicrobial disease?. Nat Rev Microbiol. 2005, 3: 182-187. 10.1038\/nrmicro1089.","journal-title":"Nat Rev Microbiol"},{"key":"163_CR4","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nrmicro2015","volume":"6","author":"DA Thorley-Lawson","year":"2008","unstructured":"Thorley-Lawson DA, Allday MJ: The curious case of the tumour virus: 50 years of Burkitt's lymphoma. Nat Rev Microbiol. 2008, 6: 913-924. 10.1038\/nrmicro2015.","journal-title":"Nat Rev Microbiol"},{"key":"163_CR5","first-page":"S111","volume-title":"East Afr Med J","author":"OW Mwanda","year":"2004","unstructured":"Mwanda OW, Rochford R, Rainey J, Wilson ML: Challenges in the epidemiological and clinical aspects of Burkitt's lymphoma in Kenya: linking evidence and experience. East Afr Med J. 2004, S111-116."},{"key":"163_CR6","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1002\/ijc.23800","volume":"123","author":"MD Ogwang","year":"2008","unstructured":"Ogwang MD, Bhatia K, Biggar RJ, Mbulaiteye SM: Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Int J Cancer. 2008, 123: 2658-2663. 10.1002\/ijc.23800.","journal-title":"Int J Cancer"},{"key":"163_CR7","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/j.1365-3156.2007.01875.x","volume":"12","author":"JJ Rainey","year":"2007","unstructured":"Rainey JJ, Mwanda WO, Wairiumu P, Moormann AM, Wilson ML, Rochford R: Spatial distribution of Burkitt's lymphoma in Kenya and association with malaria risk. Trop Med Int Health. 2007, 12: 936-943. 10.1111\/j.1365-3156.2007.01875.x.","journal-title":"Trop Med Int Health"},{"key":"163_CR8","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/ijc.23254","volume":"122","author":"LM Carpenter","year":"2008","unstructured":"Carpenter LM, Newton R, Casabonne D, Ziegler J, Mbulaiteye S, Mbidde E, Wabinga H, Jaffe H, Beral V: Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda. Int J Cancer. 2008, 122: 1319-1323. 10.1002\/ijc.23254.","journal-title":"Int J Cancer"},{"key":"163_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.semcancer.2009.07.004","volume":"19","author":"M Rowe","year":"2009","unstructured":"Rowe M, Kelly GL, Bell AI, Rickinson AB: Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology. Semin Cancer Biol. 2009, 19: 377-388. 10.1016\/j.semcancer.2009.07.004.","journal-title":"Semin Cancer Biol"},{"key":"163_CR10","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrc1452","volume":"4","author":"LS Young","year":"2004","unstructured":"Young LS, Rickinson AB: Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004, 4: 757-768. 10.1038\/nrc1452.","journal-title":"Nat Rev Cancer"},{"key":"163_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ijc.10372","volume":"99","author":"SA Xue","year":"2002","unstructured":"Xue SA, Labrecque LG, Lu QL, Ong SK, Lampert IA, Kazembe P, Molyneux E, Broadhead RL, Borgstein E, Griffin BE: Promiscuous expression of Epstein-Barr virus genes in Burkitt's lymphoma from the central African Country Malawi. Int J Cancer. 2002, 99: 635-643. 10.1002\/ijc.10372.","journal-title":"Int J Cancer"},{"key":"163_CR12","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1182\/blood.V86.2.659.bloodjournal862659","volume":"86","author":"G Niedobitek","year":"1995","unstructured":"Niedobitek G, Agathanggelou A, Rowe M, Jones EL, Jones DB, Turyaguma P, Oryema J, Wright DH, Young LS: Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma. Blood. 1995, 86: 659-665.","journal-title":"Blood"},{"key":"163_CR13","first-page":"2655","volume-title":"Fields Virology","author":"A Rickinson","year":"2007","unstructured":"Rickinson A, Kieff E: Epstein-Barr Virus. Fields Virology. Edited by: Knipe DM, Howley PM. 2007, Philadelphia: Lippincott Williams and Wilkins, 2655-2700. 5","edition":"5"},{"key":"163_CR14","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/274756a0","volume":"274","author":"G de-The","year":"1978","unstructured":"de-The G, Geser A, Day NE, Tukei PM, Williams EH, Beri DP, Smith PG, Dean AG, Bronkamm GW, Feorino P, Henle W: Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature. 1978, 274: 756-761. 10.1038\/274756a0.","journal-title":"Nature"},{"key":"163_CR15","doi-asserted-by":"publisher","first-page":"e2505","DOI":"10.1371\/journal.pone.0002505","volume":"3","author":"N Mutalima","year":"2008","unstructured":"Mutalima N, Molyneux E, Jaffe H, Kamiza S, Borgstein E, Mkandawire N, Liomba G, Batumba M, Lagos D, Gratrix F, et al.: Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study. PLoS One. 2008, 3: e2505-10.1371\/journal.pone.0002505.","journal-title":"PLoS One"},{"key":"163_CR16","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/jmv.21485","volume":"81","author":"E Piriou","year":"2009","unstructured":"Piriou E, Kimmel R, Chelimo K, Middeldorp JM, Odada PS, Ploutz-Snyder R, Moormann AM, Rochford R: Serological evidence for long-term Epstein-Barr virus reactivation in children living in a holoendemic malaria region of Kenya. J Med Virol. 2009, 81: 1088-1093. 10.1002\/jmv.21485.","journal-title":"J Med Virol"},{"key":"163_CR17","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1128\/CVI.00135-08","volume":"15","author":"AD Gu","year":"2008","unstructured":"Gu AD, Mo HY, Xie YB, Peng RJ, Bei JX, Peng J, Li MY, Chen LZ, Feng QS, Jia WH, Zeng YX: Evaluation of a multianalyte profiling assay and an enzyme-linked immunosorbent assay for serological examination of Epstein-Barr virus-specific antibody responses in diagnosis of nasopharyngeal carcinoma. Clin Vaccine Immunol. 2008, 15: 1684-1688. 10.1128\/CVI.00135-08.","journal-title":"Clin Vaccine Immunol"},{"key":"163_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/cyto.10140","volume":"50","author":"MC Earley","year":"2002","unstructured":"Earley MC, Vogt RF, Shapiro HM, Mandy FF, Kellar KL, Bellisario R, Pass KA, Marti GE, Stewart CC, Hannon WH: Report from a workshop on multianalyte microsphere assays. Cytometry. 2002, 50: 239-242. 10.1002\/cyto.10140.","journal-title":"Cytometry"},{"key":"163_CR19","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1002\/1097-0142(19800315)45:6<1507::AID-CNCR2820450634>3.0.CO;2-D","volume":"45","author":"I Magrath","year":"1980","unstructured":"Magrath I, Lee YJ, Anderson T, Henle W, Ziegler J, Simon R, Schein P: Prognostic factors in Burkitt's lymphoma: importance of total tumor burden. Cancer. 1980, 45: 1507-1515. 10.1002\/1097-0142(19800315)45:6<1507::AID-CNCR2820450634>3.0.CO;2-D.","journal-title":"Cancer"},{"key":"163_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/infdis\/170.1.13","volume":"170","author":"WM van Grunsven","year":"1994","unstructured":"van Grunsven WM, Spaan WJ, Middeldorp JM: Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein. J Infect Dis. 1994, 170: 13-19.","journal-title":"J Infect Dis"},{"key":"163_CR21","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1086\/314704","volume":"179","author":"P Meij","year":"1999","unstructured":"Meij P, Vervoort MB, Aarbiou J, van Dissel P, Brink A, Bloemena E, Meijer CJ, Middeldorp JM: Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases. J Infect Dis. 1999, 179: 1108-1115. 10.1086\/314704.","journal-title":"J Infect Dis"},{"key":"163_CR22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/(SICI)1096-9071(199904)57:4<383::AID-JMV10>3.0.CO;2-3","volume":"57","author":"E Drouet","year":"1999","unstructured":"Drouet E, Brousset P, Fares F, Icart J, Verniol C, Meggetto F, Schlaifer D, Desmorat-Coat H, Rigal-Huguet F, Niveleau A, Delsol G: High Epstein-Barr virus serum load and elevated titers of anti-ZEBRA antibodies in patients with EBV-harboring tumor cells of Hodgkin's disease. J Med Virol. 1999, 57: 383-389. 10.1002\/(SICI)1096-9071(199904)57:4<383::AID-JMV10>3.0.CO;2-3.","journal-title":"J Med Virol"},{"key":"163_CR23","first-page":"803","volume":"47","author":"EL Tan","year":"2006","unstructured":"Tan EL, Looi LM, Sam CK: Evaluation of plasma Epstein-Barr virus DNA load as a prognostic marker for nasopharyngeal carcinoma. Singapore Med J. 2006, 47: 803-807.","journal-title":"Singapore Med J"},{"key":"163_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jcv.2007.09.010","volume":"41","author":"R Dardari","year":"2008","unstructured":"Dardari R, Menezes J, Drouet E, Joab I, Benider A, Bakkali H, Kanouni L, Jouhadi H, Benjaafar N, El Gueddari B, et al.: Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma. J Clin Virol. 2008, 41: 96-103. 10.1016\/j.jcv.2007.09.010.","journal-title":"J Clin Virol"},{"key":"163_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/(SICI)1097-0215(19990331)81:1<6::AID-IJC2>3.0.CO;2-2","volume":"81","author":"LG Labrecque","year":"1999","unstructured":"Labrecque LG, Xue SA, Kazembe P, Phillips J, Lampert I, Wedderburn N, Griffin BE: Expression of Epstein-Barr virus lytically related genes in African Burkitt's lymphoma: correlation with patient response to therapy. Int J Cancer. 1999, 81: 6-11. 10.1002\/(SICI)1097-0215(19990331)81:1<6::AID-IJC2>3.0.CO;2-2.","journal-title":"Int J Cancer"},{"key":"163_CR26","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.1182\/blood.V87.12.5279.bloodjournal87125279","volume":"87","author":"I Araujo","year":"1996","unstructured":"Araujo I, Foss HD, Bittencourt A, Hummel M, Demel G, Mendonca N, Herbst H, Stein H: Expression of Epstein-Barr virus-gene products in Burkitt's lymphoma in Northeast Brazil. Blood. 1996, 87: 5279-5286.","journal-title":"Blood"},{"key":"163_CR27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.5858\/2004-128-549-ESOEVL","volume":"128","author":"S Fujita","year":"2004","unstructured":"Fujita S, Buziba N, Kumatori A, Senba M, Yamaguchi A, Toriyama K: Early stage of Epstein-Barr virus lytic infection leading to the \"starry sky\" pattern formation in endemic Burkitt lymphoma. Arch Pathol Lab Med. 2004, 128: 549-552.","journal-title":"Arch Pathol Lab Med"},{"key":"163_CR28","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/ijc.24014","volume":"124","author":"AM Moormann","year":"2009","unstructured":"Moormann AM, Heller KN, Chelimo K, Embury P, Ploutz-Snyder R, Otieno JA, Oduor M, Munz C, Rochford R: Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-gamma T cell responses. Int J Cancer. 2009, 124: 1721-1726. 10.1002\/ijc.24014.","journal-title":"Int J Cancer"},{"key":"163_CR29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/15513819709168582","volume":"17","author":"BB Rogers","year":"1997","unstructured":"Rogers BB, Conlin C, Timmons CF, Dawson DB, Krisher K, Andrews WS: Epstein-Barr virus PCR correlated with viral histology and serology in pediatric liver transplant patients. Pediatr Pathol Lab Med. 1997, 17: 391-400. 10.1080\/107710497174705.","journal-title":"Pediatr Pathol Lab Med"},{"key":"163_CR30","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1097\/QAD.0b013e3282eeeba0","volume":"21","author":"SJ Stevens","year":"2007","unstructured":"Stevens SJ, Smits PH, Verkuijlen SA, Rockx DA, van Gorp EC, Mulder JW, Middeldorp JM: Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription. Aids. 2007, 21: 2141-2149. 10.1097\/QAD.0b013e3282eeeba0.","journal-title":"Aids"},{"issue":"Pt 6","key":"163_CR31","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1099\/0022-1317-76-6-1393","volume":"76","author":"R Tedeschi","year":"1995","unstructured":"Tedeschi R, Foong YT, Cheng HM, dePaoli P, Lehtinen T, Elfborg T, Dillner J: The disease associations of the antibody response against the Epstein-Barr virus transactivator protein ZEBRA can be separated into different epitopes. J Gen Virol. 1995, 76 (Pt 6): 1393-1400. 10.1099\/0022-1317-76-6-1393.","journal-title":"J Gen Virol"},{"key":"163_CR32","first-page":"4059","volume":"24","author":"JY Shao","year":"2004","unstructured":"Shao JY, Zhang Y, Li YH, Gao HY, Feng HX, Wu QL, Cui NJ, Cheng G, Hu B, Hu LF, et al.: Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma. Anticancer Res. 2004, 24: 4059-4066.","journal-title":"Anticancer Res"},{"key":"163_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ijc.22179","volume":"120","author":"JJ Rainey","year":"2007","unstructured":"Rainey JJ, Omenah D, Sumba PO, Moormann AM, Rochford R, Wilson ML: Spatial clustering of endemic Burkitt's lymphoma in high-risk regions of Kenya. Int J Cancer. 2007, 120: 121-127. 10.1002\/ijc.22179.","journal-title":"Int J Cancer"},{"key":"163_CR34","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1086\/428910","volume":"191","author":"AM Moormann","year":"2005","unstructured":"Moormann AM, Chelimo K, Sumba OP, Lutzke ML, Ploutz-Snyder R, Newton D, Kazura J, Rochford R: Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. J Infect Dis. 2005, 191: 1233-1238. 10.1086\/428910.","journal-title":"J Infect Dis"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-9378-5-13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T04:30:15Z","timestamp":1630470615000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/1750-9378-5-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,28]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["163"],"URL":"https:\/\/doi.org\/10.1186\/1750-9378-5-13","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,28]]},"assertion":[{"value":"7 May 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"13"}}